NCT04400448

Brief Summary

Currently, due to the effects of COVID-19 pandemic, there is an imperative need to change the healthcare model. In this regard, telemedicine has proved very useful in health crises, in which there is a possibility of infection between people, offering remote access to medical care. Telemedicine has been used in many chronic diseases such as asthma and chronic obstructive pulmonary disease, diabetes mellitus, and appears to be well accepted by patients. However, few studies have been conducted in surgical services and in other diseases. Therefore, the aim of this study is to assess the level of acceptance of the patients, in this pandemic situation, to a telemedicine follow-up in different departments. This is an observational, cross-sectional, multicenter and international study with prospective and retrospective data collection. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ). In addition, all patients will provide an overall satisfaction score for telemedicine on a scale from 1 to 5 (1=lowest; 5=highest satisfaction).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2020

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

3 months

First QC Date

May 14, 2020

Last Update Submit

May 26, 2020

Conditions

Keywords

telemedicinepatient acceptancecovid-19

Outcome Measures

Primary Outcomes (1)

  • Acceptance of telemedicine

    Acceptance of telemedicine in consultations during the COVID-19 pandemic. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ) as a model. The resulting questionnaire has 10 questions.

    1 month

Secondary Outcomes (1)

  • Patient satisfaction

    1 month

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who met the described inclusion criteria will be included in the registry. Participants will be asked to answer an anonymous and voluntary questionnaire by telephone, that will be completed online by the researcher and collaborators through a Google form, aimed to assess the acceptance of the use of telemedicine in consultations during the pandemic.

You may qualify if:

  • Patients contacted by telemedicine (phone and/or video call) during the COVID-19 pandemic in outpatient clinics
  • Follow-up of patients with any chronic disease and postoperative patients, preoperative and urgent consultation
  • Age greater than or equal to 18 years

You may not qualify if:

  • Patients with cognitive or sensory difficulties or with insufficient comprehension of the language in which the survey is conducted
  • Patients who decline to take part in the telephone survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Colorectal Surgeon Hospital General Universitario Elche

Study Record Dates

First Submitted

May 14, 2020

First Posted

May 22, 2020

Study Start

June 1, 2020

Primary Completion

August 31, 2020

Study Completion

October 31, 2020

Last Updated

May 28, 2020

Record last verified: 2020-05